Using various methods to increase the secretion of GLP-1 may provide alternative therapeutic options to treat metabolic disorders such as obesity, diabetes, and NAFLD which may be due to the lack of GLP-1. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.